189 related articles for article (PubMed ID: 10204742)
1. Nicotinic cholinergic receptors: potential targets for inflammatory pain relief.
Lawand NB; Lu Y; Westlund KN
Pain; 1999 Mar; 80(1-2):291-9. PubMed ID: 10204742
[TBL] [Abstract][Full Text] [Related]
2. Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain.
Kesingland AC; Gentry CT; Panesar MS; Bowes MA; Vernier JM; Cube R; Walker K; Urban L
Pain; 2000 May; 86(1-2):113-8. PubMed ID: 10779668
[TBL] [Abstract][Full Text] [Related]
3. Gabapentin attenuates nociceptive behaviors in an acute arthritis model in rats.
Lu Y; Westlund KN
J Pharmacol Exp Ther; 1999 Jul; 290(1):214-9. PubMed ID: 10381778
[TBL] [Abstract][Full Text] [Related]
4. Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats.
Boyce S; Webb JK; Shepheard SL; Russell MGN; Hill RG; Rupniak NMJ
Pain; 2000 Apr; 85(3):443-450. PubMed ID: 10781917
[TBL] [Abstract][Full Text] [Related]
5. A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception.
Khan IM; Stanislaus S; Zhang L; Taylor P; Yaksh TL
J Pharmacol Exp Ther; 2001 Apr; 297(1):230-9. PubMed ID: 11259549
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antinociception by nicotinic receptor agonist epibatidine and adrenal medullary transplants in the spinal subarachnoid space.
Caban AJ; Hama AT; Lee JW; Sagen J
Neuropharmacology; 2004 Jul; 47(1):106-16. PubMed ID: 15165838
[TBL] [Abstract][Full Text] [Related]
7. Antihyperalgesic activity of epibatidine in the formalin model of facial pain.
Gilbert SD; Clark TM; Flores CM
Pain; 2001 Jan; 89(2-3):159-65. PubMed ID: 11166471
[TBL] [Abstract][Full Text] [Related]
8. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (+/-)-epibatidine in rats.
Curzon P; Nikkel AL; Bannon AW; Arneric SP; Decker MW
J Pharmacol Exp Ther; 1998 Dec; 287(3):847-53. PubMed ID: 9864263
[TBL] [Abstract][Full Text] [Related]
9. Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists.
Khan IM; Buerkle H; Taylor P; Yaksh TL
Neuropharmacology; 1998 Dec; 37(12):1515-25. PubMed ID: 9886674
[TBL] [Abstract][Full Text] [Related]
10. Reduction in joint swelling and hyperalgesia following post-treatment with a non-NMDA glutamate receptor antagonist.
Sluka KA; Jordan HH; Westlund KN
Pain; 1994 Oct; 59(1):95-100. PubMed ID: 7854809
[TBL] [Abstract][Full Text] [Related]
11. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
12. Analgesic effects of Sazetidine-A, a new nicotinic cholinergic drug.
Cucchiaro G; Xiao Y; Gonzalez-Sulser A; Kellar KJ
Anesthesiology; 2008 Sep; 109(3):512-9. PubMed ID: 18719450
[TBL] [Abstract][Full Text] [Related]
13. The effect of ketamine on intraspinal acetylcholine release: involvement of spinal nicotinic receptors.
Abelson KS; Goldkuhl RR; Nylund A; Höglund AU
Eur J Pharmacol; 2006 Mar; 534(1-3):122-8. PubMed ID: 16612840
[TBL] [Abstract][Full Text] [Related]
14. Modulatory role of estradiol in nicotinic antinociception in adult female rats.
Chen Y; Cui Y; Lin JW; Xiang QL; Liu WF; Wang TH
Life Sci; 2009 Jul; 85(1-2):91-6. PubMed ID: 19427872
[TBL] [Abstract][Full Text] [Related]
15. Group I metabotropic glutamate receptor antagonists block secondary thermal hyperalgesia in rats with knee joint inflammation.
Zhang L; Lu Y; Chen Y; Westlund KN
J Pharmacol Exp Ther; 2002 Jan; 300(1):149-56. PubMed ID: 11752110
[TBL] [Abstract][Full Text] [Related]
16. Spinal mechanisms underlying A-85380-induced effects on acute thermal pain.
Rueter LE; Meyer MD; Decker MW
Brain Res; 2000 Jul; 872(1-2):93-101. PubMed ID: 10924680
[TBL] [Abstract][Full Text] [Related]
17. Mecamylamine prevents tolerance but enhances whole brain [3H]epibatidine binding in response to repeated nicotine administration in rats.
McCallum SE; Caggiula AR; Booth S; Breese CR; Lee MJ; Donny EC; Leonard S; Sved AF
Psychopharmacology (Berl); 2000 May; 150(1):1-8. PubMed ID: 10867970
[TBL] [Abstract][Full Text] [Related]
18. (+/-) Epibatidine increases acetylcholine release partly through an action on muscarinic receptors.
Kommalage M; Höglund AU
Basic Clin Pharmacol Toxicol; 2004 May; 94(5):238-44. PubMed ID: 15125694
[TBL] [Abstract][Full Text] [Related]
19. The dorsal raphe nucleus as a site of action of the antinociceptive and behavioral effects of the alpha4 nicotinic receptor agonist epibatidine.
Cucchiaro G; Chaijale N; Commons KG
J Pharmacol Exp Ther; 2005 Apr; 313(1):389-94. PubMed ID: 15608080
[TBL] [Abstract][Full Text] [Related]
20. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors.
Bannon AW; Decker MW; Holladay MW; Curzon P; Donnelly-Roberts D; Puttfarcken PS; Bitner RS; Diaz A; Dickenson AH; Porsolt RD; Williams M; Arneric SP
Science; 1998 Jan; 279(5347):77-81. PubMed ID: 9417028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
